Cargando…
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) locus lead to defective proteins and reduced Cl(-) secretion and N...
Autores principales: | Eickmeier, Olaf, Fussbroich, Daniela, Mueller, Klaus, Serve, Friederike, Smaczny, Christina, Zielen, Stefan, Schubert, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291435/ https://www.ncbi.nlm.nih.gov/pubmed/28158236 http://dx.doi.org/10.1371/journal.pone.0171249 |
Ejemplares similares
-
Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
por: Ludwig, M, et al.
Publicado: (2014) -
A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA
por: Fussbroich, D., et al.
Publicado: (2020) -
Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis
por: Horn, Tabea, et al.
Publicado: (2020) -
Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018) -
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
por: Meoli, Aniello, et al.
Publicado: (2022)